Oxymetazoline
Category: topical
Aliases: Afrin
Pharmacological Mechanism
Imidazoline α1A + partial α2 adrenergic agonist — topical vasoconstrictor for nasal congestion. Rebound congestion (rhinitis medicamentosa) develops with use >3 days. Topical formulation also approved for adult facial rosacea erythema (Rhofade).
Half-Life (t½)
IN: 6h
Dosing Guidelines
- IN: Typical 0.05 mg (Range: 0.05–0.05 mg)
Target Organ Systems
- cardiovascular
- integumentary
Chemical Identifiers
- PubChem CID: 4636
- Formula: C16H24N2O
- Molecular weight: 260.38 g/mol
- InChIKey: WYWIFABBXFUGLM-UHFFFAOYSA-N
- SMILES: CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C